We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
71 hedge funds and large institutions have $105M invested in State Street SPDR S&P Pharmaceuticals ETF in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
22% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 18
20% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 10
13% more capital invested
Capital invested by funds: $93.1M → $105M (+$11.8M)
12.37% more ownership
Funds ownership: 41.93% → 54.29% (+12%)
3% more funds holding
Funds holding: 69 → 71 (+2)
100% less call options, than puts
Call options by funds: $3K | Put options by funds: $853K
Holders
71
Holders Change
+2
Holders Change %
+2.9%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
22
Reduced
18
Closed
10
Calls
$3K
Puts
$853K
Net Calls
-$850K
Net Calls Change
-$514K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$17M |
| 2 |
Morgan Stanley
New York
|
+$6.5M |
| 3 |
CCMG
Clark Capital Management Group
Philadelphia,
Pennsylvania
|
+$4.71M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.97M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$3.76M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$19.1M |
| 2 |
FFM
Fullerton Fund Management
Singapore
|
-$1.34M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.31M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$801K |
| 5 |
Jane Street
New York
|
-$553K |
